Veronika Litinski is CEO at GeneYouIn Inc., a personalized medicine company. Bringing to market the genomics-guided medication management service, PillCheck, Veronika is leveraging the best of scientific and entrepreneurial cultures in this new era of data-powered decision making. In her role as CEO, Veronika is drawing upon a decade’s experience launching innovative products in the medical sector, building winning alliances and capitalizing opportunities in the health and wellness revolution. Veronika led the Health practice, from its inception, at MaRS Discovery District in Toronto. MaRS helps entrepreneurs launch and grow the innovative companies that are building our future. Collaborating with Baycrest Hospital, the world's leading centre for the study of memory and aging, she also piloted the launch of Cogniciti, a digital health product suite that has since helped millions of aging adults with significant memory concerns. Prior to her career in Digital Health, Veronika helped grow the Venture Finance arm of GATX Capital in San Francisco. A chemist by training, Veronika first discovered her passion for health sciences as a cancer researcher at Lawrence Berkeley National Laboratory in California.
By enhancing the ability of doctors to select prescription drugs that better interact with an individual's inherited genetic variations, pharmacogenetics may hold a key to improving med...
Our paper published in the prestigious journal Benefits Quarterly. The article describes how methods of personalized medicine -- specifically, pharmacogenetic (PGx) testing -- can benef...